Minerva Seeks FDA Approval For Its Schizophrenia Candidate
Minerva Neurosciences Inc (NASDAQ:NERV) submitted a marketing application to the FDA for roluperidone for negative symptoms in patients with schizophrenia. “We…
Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off
Cue Biopharma (NASDAQ: CUE) has dosed the first patient in a Phase 1 dose escalation study evaluating CUE-102 for the treatment of patients with Wilms' Tumor 1 (WT1)-positive recurrent/metastatic cancers.
Revlon Climbs, Singing Machine Moves Up And Weber Makes Big Move: 5 Short Squeeze Stocks That May Soar This Week
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.
$3 Million Bet On This Communication Services Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones dropped more than 290 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Why Should Cannabis Investors Pay Attention To Germany? These Stocks Will Benefit From Imminent Legalization
With US federal legalization stalled and its near-term outcome uncertain, cannabis stocks are taking a hit. Cantor Fitzgerald's analyst Pablo Zuanic advised investors to turn their interest to Germany, or at least for now.
Minerva Seeks FDA Approval For Schizophrenia Candidate
Minerva Neurosciences (NASDAQ: NERV) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for roluperidone in the treatment of negative symptoms for patients with schizophrenia.
SNDL To Buy Valens For $105M In Stock Creating Cannabis Behemoth
SNDL Inc. (NASDAQ: SNDL) and The Valens Company Inc.
NHWK: Scorpion Grand Opening 3Q:22
By John Vandermosten, CFA
NYSE:NHWK
READ THE FULL NHWK RESEARCH REPORT
Why XORTX Therapeutics Stock Is Rising Today
XORTX Therapeutics Inc (NASDAQ: XRTX) shares are trading higher Monday after the company announced positive results from its pharmacokinetics bridging study.